Register before 31 December 2016 for exclusive early rates.
Organized by Partners HealthCare, the World Neuroscience Innovation Forum is a tailored, neuroscience gathering that builds on the broad success of the flagship Annual Forums. It will feature highly-interactive exchanges among neuroscience leaders, with the aim of turning insights into action.
The goal of the London Forum is to spark new insights, therapeutic paths and collaborations to combat neuroinflammation and neurodegeneration found in diseases such as Alzheimer’s and multiple sclerosis.
We are collaborating with Brigham and Women’s Hospital, Massachusetts General Hospital, Partners HealthCare and Harvard Medical School and invite you to the 2017 World Neuroscience Innovation Forum, 27 March 2016.
Forum keynote speakers include senior leadership from Teva, Otsuka, Alzheimer’s Research UK, AstraZeneca and dozens of top investors, and senior Harvard faculty. Be part of the new urgency to redefine neuroinflammation and neurodegeneration through new therapies, platforms and engagement.